Robb E Wilentz
Overview
Explore the profile of Robb E Wilentz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cao D, Wilentz R, Abbruzzese J, Ho L, Maitra A
Int J Gastrointest Cancer
. 2005 Oct;
36(1):39-46.
PMID: 16227634
Background: Maspin is both overexpressed in tumors and inflammation, implicating a possible role in bridging inflammation and neoplasia. Idiopathic inflammatory bowel disease (IBD) and IBD-associated dysplasias and carcinomas represent a...
2.
Hansel D, Ashfaq R, Rahman A, Wanzer D, Yeo C, Wilentz R, et al.
Am J Clin Pathol
. 2005 Mar;
123(1):28-35.
PMID: 15762277
We sought to identify the frequency of amplification of the topoisomerase IIalpha gene (TOP2A) in pancreatic cancer and determine the usefulness of TOP2A immunolabeling in screening for TOP2A and human...
3.
Hansel D, Rahman A, Wilentz R, Shih I, McMaster M, Yeo C, et al.
Int J Gastrointest Cancer
. 2005 Feb;
35(1):15-23.
PMID: 15722570
HLA-G belongs to the nonclassical MHC class Ib group of molecules and has been implicated in mediating immune-responsiveness in various cancerous and non-cancerous cell types. We have examined HLA-G expression...
4.
Sahin F, Qiu W, Wilentz R, Iacobuzio-Donahue C, Grosmark A, Su G
Pancreas
. 2005 Feb;
30(2):158-67.
PMID: 15714138
Objectives: Establishing more effective treatment of pancreatic cancer requires an understanding of the molecular events leading to the onset and progression of this disease. The biology of tumorigenesis may be...
5.
Wilentz R, Rahman A, Argani P, Iacobuzio-Donahue C
Methods Mol Med
. 2004 Nov;
103:67-88.
PMID: 15542898
There are many types of pancreatic neoplasms. Pathologic examination, which includes both routine (e.g., hematoxylin-and-eosin staining) and ancillary (e.g., immunohistochemistry and in situ hybridization) techniques, is essential in correctly typing...
6.
Hruban R, Wilentz R, Maitra A
Methods Mol Med
. 2004 Nov;
103:1-13.
PMID: 15542896
Histologically distinct noninvasive precursor lesions have been recognized in the pancreas for close to a century. The recent development of a consistent reproducible nomenclature and classification system for these lesions...
7.
Storm P, Renard V, Moriarity J, Tyler B, Wilentz R, Brem H, et al.
Cancer Chemother Pharmacol
. 2004 Jun;
54(4):361-7.
PMID: 15197484
Purpose: To investigate the ability of systemically delivered BCNU to enhance the activity of either systemically delivered irinotecan (CPT-11) or locally delivered camptothecin from a biodegradable polymer for treatment of...
8.
Rosty C, Geradts J, Sato N, Wilentz R, Roberts H, Sohn T, et al.
Am J Surg Pathol
. 2003 Dec;
27(12):1495-501.
PMID: 14657708
Patients with long-standing chronic pancreatitis are thought to be at increased risk of developing pancreatic ductal adenocarcinoma, but the mechanism for this increased risk is unknown. Since increasing evidence supports...
9.
McCarthy D, Maitra A, Argani P, Rader A, Faigel D, Van Heek N, et al.
Appl Immunohistochem Mol Morphol
. 2003 Sep;
11(3):238-43.
PMID: 12966350
The interpretation of pancreas fine-needle aspiration (FNA) is extremely difficult given the cytologic overlap of neoplastic and reactive processes. Using serial analysis of gene expression, we have discovered 2 new...
10.
Montgomery E, Wilentz R, Argani P, Fisher C, Hruban R, Kern S, et al.
Cancer Biol Ther
. 2003 Jul;
2(3):248-52.
PMID: 12878857
A classification of neoplasms as chromosomally stable vs. unstable is of importance in assessing inherited risks but is primarily defined in cell lines where rates of instability can be directly...